Dr Reddy’s receives DCGI approval to conduct phase 2/3 trials of Sputnik V vaccine in India
Dr Reddy’s receives DCGI approval to conduct phase 2/3 trials of Sputnik V vaccine in India
Indian Express
0 shares
1 views
You might like
Related news coverage
Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India
IndiaTimes
After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct..
-
Sputnik V Covid-19 vaccine gets nod for clinical trials in India
Mid-Day
-
Dr Reddy's gets DCGI nod for trial of Covid vaccine Sputnik V in India
IndiaTimes
-
Sputnik V Covid-19 vaccine made by Russia gets nod for clinical trials in India
Zee News
-
Dr. Reddy’s, RDIF get DCGI nod for Sputnik V clinical trial
Hindu
Advertisement
More coverage
Long Road Ahead To COVID-19 Immunity Even With Vaccines – OpEd
By Prabir Purkayastha*
As the pandemic continues to spread throughout the world, many countries seem to have given up..
Eurasia Review